Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Inovio Pharmaceuticals Inc (INO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Inovio's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
10.3700 +0.3500    +3.49%
16:00:04 - Closed. Currency in USD ( Disclaimer )
After Hours
10.3686
-0.0014
-0.0135%
17:53:20 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 238,775
  • Bid/Ask: 10.2100 / 10.3700
  • Day's Range: 9.9500 - 10.8168
Inovio 10.3700 +0.3500 +3.49%

Inovio Pharmaceuticals Inc Company Profile

 
Get an in-depth profile of Inovio Pharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

122

Equity Type

ORD

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

Contact Information

Address 660 West Germantown Pike Suite 110
Plymouth Meeting, 19462
United States
Phone 267 440 4200
Fax -

Top Executives

Name Age Since Title
Simon X. Benito 76 2003 Independent Chairman of Board of Directors
Wendy L. Yarno 68 2017 Independent Director
Jacqueline E. Shea 56 2019 CEO, President & Director
Roger D. Dansey 66 2021 Independent Director
David B. Weiner 67 2000 Chairman of the Scientific Advisory Board & Director
Rafi Ahmed - 2018 Member of Scientific Advisory Board
Lota S. Zoth 63 2019 Independent Director
Stanley A. Plotkin 90 2009 Member of Scientific Advisory Board
Anthony W. Ford-Hutchinson - 2012 Member of Scientific Advisory Board
Ann Calby Miller 64 2019 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

INO Comments

Write your thoughts about Inovio Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Clayton Fanning
Clayton Fanning Jan 31, 2024 6:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow ....up in pre...will be another loser day
Clayton Fanning
Clayton Fanning Jan 26, 2024 4:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will be back down to .67 soon
Антон Ю
Антон Ю Dec 29, 2023 9:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Short-squeze
Антон Ю
Антон Ю Dec 29, 2023 8:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
All Buy. History Game Stop, commom
Clayton Fanning
Clayton Fanning Oct 06, 2023 4:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Banner Day ....Ino Management Blows...Should All Be In Jail
Claus Østerballe
Claus Østerballe Sep 29, 2023 10:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy or leave it?
Clayton Fanning
Clayton Fanning Mar 28, 2023 1:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Shooting For $0
Clayton Fanning
Clayton Fanning Feb 21, 2023 5:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What a bunch of thieves....Stock Manipulation...Hope Dr Emmett Brown Rots in Jail
Mohamed Alnaqbi
Mohamed Alnaqbi Feb 21, 2023 5:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I invested 15 grand in this dam stock years ago. today it worth 8 dollars. it is true, they are thieves.
Omar Jabbour
Omar Jabbour Feb 21, 2023 5:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Mohamed Alnaqbi can we sue ? Those thieves
Clayton Fanning
Clayton Fanning Feb 02, 2023 2:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will be red real soon
Clayton Fanning
Clayton Fanning Jan 01, 2023 10:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Did anybody else know that Kim resigned his position w Ino a few months ago ? Hopefully he is going to jail...
KeepIt Real
KeepIt Real Jan 01, 2023 10:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Can you post the source?
Clayton Fanning
Clayton Fanning Jan 01, 2023 10:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
just google Dr Kim Inovio resigns
Clayton Fanning
Clayton Fanning Jan 01, 2023 10:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hopefully the Quack goes to Jail for stock fraud
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email